Compare

Nexentis Technologies Inc. vs Incannex Healthcare Inc. vs Jyong Biotech Ltd. vs Galectin Therapeutics Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Nexentis Technologies Inc. NXTS	Incannex Healthcare Inc. IXHL	Jyong Biotech Ltd. MENS	Galectin Therapeutics Inc GALT
Year ended	2025-12-31	2025-06-30	2025-12-31	2025-12-31
Revenue	n/a	$86.0K	n/a	n/a
Revenue growth (YoY)	n/a	+616.7%	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/m	n/a	n/a
Net margin	n/a	n/m	n/a	n/a
Net income	-$4.00M	-$46.88M	-$4.67M	-$30.84M
EPS (Diluted)	-$8.61	-$1.35	-$0.06	-$0.48
Operating cash flow	-$3.81M	-$12.51M	-$3.04M	-$23.88M
Free cash flow	-$3.82M	-$12.52M	n/a	n/a
Cash & equivalents	$3.83M	$15.04M	n/a	$17.72M
Total assets	$20.41M	$20.45M	$20.78M	$19.53M
Total liabilities	$4.67M	$7.06M	$45.68M	$145.73M
Shareholders' equity	$16.01M	$13.39M	-$24.91M	-$127.92M
Return on year-end equity	-25.0%	-350.2%	n/a	n/a
Shares outstanding	2.77M	194.38M	76.03M	65.20M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Nexentis Technologies Inc.	Incannex Healthcare Inc.	Jyong Biotech Ltd.	Galectin Therapeutics Inc
Latest	$210.0K Ended 2024-12-31	$86.0K Ended 2025-06-30	n/a	n/a
1 year earlier	$263.0K Ended 2023-12-31	$12.0K Ended 2024-06-30	n/a	n/a
2 years earlier	$394.0K Ended 2022-12-31	n/a	n/a	n/a
3 years earlier	$438.1K Ended 2021-12-31	n/a	n/a	n/a
4 years earlier	$232.3K Ended 2020-12-31	n/a	n/a	n/a